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1. Introduction 
Ischemia reperfusion injury (I/R) is a relevant problem in case of myocardial infarction 
(Moens AL, Claeys MJ et al. 2005.), stroke, (Kato H and Kogure K 1999), coronary bypass 
surgery, (Bakkaloglu C, and Soyagir B, 2006), under thrombolysis, (Krumholz HM and 
Goldberger 2006), revascularization surgery of lower limb (Arato et al 2006., Laird IR 2003), 
balloon angioplasty (Weissand A.G. and Zahger AT 1999) and in every cases, when the 
physiological blood flow in the occluded vessels are restored (Falkensammer J and 
Oldenburg WA 2006), (Ferencz A et al 2004). Vessel closure and hypoxia can be caused by 
embolism (thrombus, tumour, fat, foreign body) stenotic arteriopathy, arterial spasm, 
compression, arterial thrombus, trauma, etc. During the exclusion of a segment of the 
vessels from the circulation, ischemia and acidosis appeared in the surrounding tissues. In 
case of the heart, when oxygen supply is inadequate, the respiration shift from aerobic fatty 
acid consumption and metabolism to anaerobic glycolysis, resulting in a reduced ATP 
production. The results of hypoxia in the metabolically active tissues (cardiac, skeletal 
muscle and neuronal tissues) are more profound than in other cell types. The cells are 
exposed to hypoxia try to adapt to the absence of oxygen, by switching their metabolism 
from aerobic to anaerobic. Finally this strategy leads to tissue damages and loss of cells too, 
as it can be seen in acute or chronic occlusive diseases, as well. The measures of the tissue 
injuries depend on the duration of hypoxia, the mass of tissues are involved, the ATP 
requirement of the cell types and the blood pressure of the patients. Under hypoxic 
condition the generations of reactive oxygen species (ROS), such as O2.-, H2O2, are increased.  
During normoxyc, physiological condition mitochondria generate low level of ROS by the 
respiratory chain. These are managed by natural antioxidants, such as manganese superoxid 
dismutase (SOD) in the mitochondria, or copper-zinc SOD in the inter-membrane space in 
the mitochondria, and in the cytosol, making the dismutation of superoxide anion 
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generation to H2O2, which transformed further by catalase, glutathion plus glutathion 
peroxydase. Under hypoxic condition several sources of free radicals activated, e.g. the 
NADPH oxydase, xanthin oxidase, and others. ROS generated by hypoxia disrupts 
respiratory chain, causing a vicious cycle, manifested in modification in permeability 
transmission, loss of membrane potential, altering the function of mitochondrial complex I, 
III, and generating ubisemiquinon radical, which donates its electron to oxygen resulting in 
superoxyde anion. In reduced oxygen tension complex II switches its activity from succinate 
dehydrogenase to fumarate reductase (Henrich M et al, 2004.), Kolamunne RT et al 2011). 
Chronic sever hypoxia induces ATP depletion, and cell death. In the course of hypoxia, ATP 
generation decrees, exhausting the ATP sources, which responsible for the overflow of 
hypoxanthine, an ATP metabolite. Hypoxanthine in normoxyc condition metabolized 
further by xanthine dehydrogenase to xanthine (by means of nicotinamide adenine 
dinucleotide (NAD) as cofactor), but during hypoxia xanthin dehydrogenase converted to 
xanthin oxidase, which is unable to catalyse this conversion, but in the presence of high 
oxygen level in reoxygenation phase it continuously generates toxic ROS, because it uses 
oxygen as cofactor. ROS are effective oxidizing and reducing agents that directly damage 
cellular membranes, leading to impairment of membrane ion channels, disturbing cellular 
ionic balance resulting in cell swelling. ROS can activate leucocytes as well, and induce 
chemotaxis, cytokine release, leukocyte infiltration into the injured tissues, and due to 
endothelium dysfunction, a systemic reperfusion inflammatory response occurs. The most 
serious consequences of IR are the development of remote organ injuries in non-ischemic 
organs and can induce systemic inflammatory response injury (SIRS) or multiorgan failure 
syndrome (MOFS) which are responsible for of 20-40% of death in intensive care units (Levy 
JH, and Tanaka KA 2003). Tough reconstruction of the flow in the occluded vessels is not 
without risk, because of the generated volume, pressure and metabolic load, accompanied 
by further tissue damages resulting in the so-called reperfusion injury.  
The main components of the molecular pathophysiological cascades are the activated 
circulating cells, first of all the white blood cells (WBC), mainly the neutrophils, due to their 
intensive free radical production, but, thrombocytes (PLT), red blood cells (RBC), and the 
cells of the vessel wall (endothelial cells and smooth muscle cells) also participate in the free 
radical production and the tissue damage (Roth and Hejjel 2003). In the early reperfusion 
the release of inflammatory cytokines, such as tumor necrosis factor alpha (TNF) increase 
too. These events together with the elevated Ca2+ levels inside the attached cells threat the 
integrity of the whole organism, destroying the crucial macromolecules, proteins, lipids and 
nucleic acids (Arato et al. 2005), (Blaisdell FW  1989).  
Reactive oxygen species are Janus-faced agents. They have important role in eliminating 
pathogen microorganisms from the body, and can regulate cell growth and differentiation. 
ROS can act as important signalling molecules, in the circulation and participate in the 
maintenance of intra- and extracellular milieu. They can induce redox sensitive transcription 
factors, regulate redox sensitive signalization cascades and can act as secondary messengers 
(Kathy K et al 2000), (Dröge W, 2002). Oxygen free radicals can act as second messengers and 
they are able to influence the function of enzymes, and transcription factors, leading to the 
induction of genes are sensitive to them (Li W et al 2008). Their intra- and extracellular 
levels are regulated by SOD and catalase (the enzymes are present in almost all living 
organisms are exposed to oxygen) and other antioxidant, respectively. On the other hand 
they can cause endothelial dysfunction due to eliminating vital nitrogenous monoxides 
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(NO), which are absolutely necessary for the endothelium dependent relaxation of the 
vessels (Moncada et al 1991), for the proper function of cardiomyocytes (Umar S, van der 
Laarse A. 2010), and for the physiological function of circulating cells, such as thrombocytes 
(Massberg S 1998) and leukocytes, and red blood cells. It can be stated that free radicals are 
both our friends and enemy at the same time (Downey JM, and Cohen MV 2008). 
It is very difficult to monitor the cellular processes which influence the outcome of the 
surgical interventions, or serves as a marker of the postoperative events. A huge amount of 
data emerged for the characterization of ischemia reperfusion injury, but function of 
platelets and other circulating cells or their interaction with each other or with endothelial 
cells has been hardly investigated  (Buchholz AM, Bruch L 2003.). Limitation of reperfusion 
injury is inevitably important to prevent tissue damages, manifested in apoptosis, necrosis 
or both, and frequently occurred after restoration of circulation after stroke, myocardial 
infarction, organ transplantations, and in all types of revascularization surgeries. There are 
pharmacologic tools, and protective processes, which can reduce IR injury. Antioxidants, 
such as N-acetylcysteine, vitamin E, mannitol, thiols, alkaloids and endogenous 
antioxidants, such as superoxide dismutase, reduced glutathion, glutathione reductase, 
catalase, or ion chelators functions due to inactivation of free radicals, which are key 
element in IR induced tissue damages (Arato et al 2010), (Peto K,  et al 2007),  but leukocyte 
depletion, anti-cytokine or leukocyte adhesion molecule monoclonal antibody therapies 
ended with conflicting results (Arato et al 2010) (Loberg AG et al ,2011). Among other 
effective possibilities, ischemic postconditioning is one of the most effective processes in 
reducing IR caused damages, which was first introduced by Vinten-Johansen’s group in 
2003. The main essence of application of short (some seconds) repetitive interruption of 
early reperfusion by brief ischemic episodes resulting in reduced infarct size in the heart, 
diminished tissue edema, reduced infiltration of leukocytes into the area of injury, as they 
were improved in animal studies (Vinten-Johansen J 2007).  
Angioplasty with or without vascular stenting is an effective method, was developed by 
Dotter and Judkins (Misty M et al 2001) to reconstruct the proper flow within the narrowed 
or occluded vessels. The procedure is carried out mainly in the coronary arteries, but it is 
frequently applied in other parts of the circulation. The procedure itself is a typical example 
of I/R injury was characterized above, with main risks of endothelium dysfunction and 
reocclusion due to thrombus formation and/or smooth muscle proliferation. The potential 
role of the circulating cells, such as PLT, WBC, and RBC in the vessel closure is intensively 
studied, and their interactions with the components of vessel wall, mainly with the smooth 
muscle cells and the endothelial linage have special attention (Ming Wei Liu et al 1989). 
Platelet leukocyte interaction is also investigated, because of their unique role in reocclusion 
(Szabo S. et al 2005). 
In the present study we aimed to investigate the function of circulating cells in the course of 
acute (emergency) and elective revascularization surgery in lower limb of patients with 
Peripheral arterial disease (PAD). In our studies thrombocyte function, antioxidant and 
prooxidant status were investigated in two groups of patients, who were scheduled to elective 
revascularization surgery (Elective) and were compared to the patients with acute vessel 
closure and were undergone revascularization surgery in emergency, 4-6 hours after of vessel 
closure (Acute). Data obtained in the two patients groups were compared to the same 
parameters of healthy veterinary blood donors (Control). Patients of the two groups (Acute 
and Elective) have other chronic diseases too, such as diabetes mellitus. Diabetes is a disease 
when patients have high blood sugar concentration due to the inadequate production: DM1, or 
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inadequate effects on the tissues of otherwise physiological or high level of circulating insulin: 
DM2. In the second series of experiments, thrombocyte function and prooxidant/antioxidant 
status of DM1 and DM2 patients with PAD were also investigated. In vitro effects of 
exogenous insulin (Actrapid Insulin (Novo-Nordisk) In 0, 40, 80, 160 µU/ml) were also 
investigated on collagen induced platelet aggregation and phorbol – 12 myristate-13 acetate 
(PMA) induced reactive oxygen species (ROS) production in whole blood.  
2. Materials and methods 
Patients selection and investigation in this randomized, open, prospective studies was 
carried out according to the Helsinki declaration (1996), considering the statute of 
Hungarian Ministry of Health (32/2005. (VIII:26), with the permission of the local ethical 
board of the Pecs University, Medical School. (Permission No.: 2498). 
2.1 The first series of experiments 
The aim of this study was to investigate the effect of the duration of hypoxia on the 
thrombocyte function, free radical production and antioxidant/prooxidant statuses of the 
patients who were undergone revascularization surgery of lower limb.  
Patients: Two groups of patients were investigated:  
1. Acute group: n=12; 9 males and 3 female, age: 58.1±7.3 years, suffered from ischemia  
4-6 hours  before  revascularization surgery of lower limb because of  seriously ischemic 
extremities due to embolism, acute arterial thrombosis or rupture of infrarenal artery 
before the surgery. They were undergone revascularization surgery in emergency.  
2. Elective group n=10, (6 male 4 female) were scheduled to elective revascularization 
surgery because of chronic obliterative arterial stenosis. Ischemia was diagnosed by 
angiography, and Doppler test.  
Other chronic diseases accompanied by PAD in our patients are summarized in Table 1.  
Surgical interventions were carried out in General and Vascular Surgery Department of 
Baranya County Hospital (Pecs; Hungary), and were performed in spinal anaesthesia, with 
43.8±17 min ischemic time. Patients of both groups received similar anticoagulant and 
antiplatelet therapy (at least 75 mg Aspirin) and low molecular weight heparin was also 
prescribed in the perioperative period. Medication of the patients is summarized in Table 2. 
 
Disease Acute group Elective group 
Hypertension 6/12 8/10 
Ischemic heart disease 3/12 4/10 
Diabetes mellitus 4/12 5/10 
Lung complications 4/12 4/10 
Smooking 5/12 4/10 
Table 1. Chronic diseases accompanied with PAD in the first series of the study 
Blood sampling: Venous blood samples were obtained by venipuncture.  Samples of 10 
healthy blood donors (Blood Donation Center of Pecs, Hungary) served as Control. Venous 
blood samples of the two patients groups were obtained before and 2 and 24 hours and one 
week after the surgery. Blood samples were collected into three Vacutainer tubes containing 
trisodium citrate (3.8%) or K3-EDTA (7.5 %) (Becton Dickinson, UK). Informed consents 
were obtained from all patients and volunteers participated in the study.  
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Groups of medicine Acute Elective 
PLT aggregation inhibitors 
(Aspirin protect or Astrix) 12/12 10/10 
Anticoagulant 
(perioperative) 12/12 10/12 
Antihypertensive 6/12 8/10 
Antidiabetic 4/12 5/10 
Others 12/12 10/10 
Table 2. Medication of patients with PAD in the 1st series of the study 
Laboratory measurements: were carried out in Department of Surgical Research and 
Techniques of Pecs University Medical School, Hungary. Hematologic measurement: red 
and white blood cell numbers, haemoglobin concentration, platelet numbers were measured 
by Minitron automatic analysator (Diatron LTD Budapest, Hungary). Platelet aggregation 
measurements:  
1. in platelet rich plasma (PRP), according to Born’s turbidimetric method (Born 1965a), 
Born et al 1965b), by means of Carat aggregometer (Carat Diagnostic ltd, Budapest, 
Hungary), using ADP (5 µM; and 10 µM) and collagen (2 µg/ml) as inductors. 
Aggregation was followed for 8 minutes after its induction and expressed in %. 
2. in whole blood was measured by the method of Ingerman-Wojenski and Silver by 
Chrono-log lumino-aggregometer (type 560VS, USA), according to the user’s manual of 
the instrument (Ingerman-Wojenski CM and Silver MJ), using the same inductors as 
was used in PRP. In whole blood platelet aggregation was measured by impedance, and 
expressed in Ohm, and was followed for six minutes from its induction. 
Measurement of main antioxidants: SOD is an ancient antioxidant enzyme of pro- and 
eukaryotic organisms, containing metal (Cu, Zn, Fe, Mn Ni, respectively) in its active centre, 
and it has several isoforms,  which can be found intra- and extracellularly, in almost all 
living creature, as well. Measurement of SOD activity was carried out by the method of 
Misra and Fridovich (Misra and Fridovich 1972). Reduced glutathione (GSH) levels were 
determined in plasma were obtained after centrifugation of anticoagulated whole blood, 
using Ellman’s reagent (Sedlak and Lindsday 1968). GSH cystein is able to neutralize free 
radicals by donating one electron and stabilizes them. In the course of this reaction it 
became reactive, as well, but an other GSH can neutralize it, forming GSSG, which will be 
regenerated to GSH by glutathione reductase. Plasma proteins (such as albumin) contain 
sulphydril groups, as well and exert remarkable antioxidant capacity though its –SH 
groups, was measured also. 
Measurement of prooxidants: Reactive oxygen species (ROS) was measured in the mixture 
of whole blood (20 µl) and phosphate buffered saline (1400 µl) by chemiluminometric, 
kinetic method, by means of Chrono-Log lumino-aggregometer. The main sources of ROS in 
the blood are leukocytes.  ROS production was induced in whole blood by phorbol -12-
miristate-13-acetate (PMA) and was made detectable by luminol (Arato et al 2010b).) 
Malondialdehyde (MDA), the main lipid peroxidation marker, which signs the 
polyunsaturated fatty acid peroxidation of the biological membranes. It was measured in 
anticoagulated whole blood and in plasma (Ohkawa H (1979). Myeloperoxidase (MPO) 
produces hypochlorous acid (HOCl) from hydrogen peroxide (H2O2) and chloride anion  
(Cl-) (or the equivalent from a non-chlorine halide) during the neutrophil's respiratory burst. 
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It requires hem as a cofactor. Furthermore, it oxidizes tyrosine to tyrosyl radical using 
hydrogen peroxide as an oxidizing agent. MPO level was measured in plasma, according to 
the method of (Xia and Zweier 1997). 
2.2 The second series of experiments 
The aim of this study 
Insulin resistance and diabetes mellitus are causal or worsening factors in the peripheral 
arterial diseases (Jude EB 2001). In the second part of the study we intended to investigate 
thrombocyte function parallel with antioxidant prooxidant status of ambulant diabetic 
(DM1 and DM2)  patients with PAD were under the care of General and Vascular Surgery 
Department of Baranya County Hospital (Pecs; Hungary). Eleven healthy volunteers of 
Blood Donation Centre of Pecs served as controls   
Methods 
This study involved 24 patients with DM1 (18 male and 6 female; age: 62 ± 2.3 year), and 22 
with DM2 (18 male and 4 female; age: 65,7 ±3.7)  with PAD. Healthy blood donors served as 
control (8 male and 2 female; age: 33 ± 6.7 years). Anticoagulated whole blood of ambulant 
patients and volunteers were used. Informed consents were obtained from all participants. 
Regular medication of the two patients group is summarized in Table 3. 
 
Medication DM1 DM2 
Platelet aggregation inhibitors 
(Aspirinprotect or Astrix) 
24/24 22/22 
Anticoagulant (Syncumar) 4/24 4/22 
Anticoagulant (LMWH) 12/24 10/22 
Antihypertensive 18/24 18/22 
Insulin 24/24 2/22 
Oral antidiabetic 0/24 20/22 
Other 24/24 22/22 
Table 3. Medication of the DM1 and DM2 patients. 
Parameters to be measured 
Clinical chemistry data: Glucose triglyceride, cholesterol was measured by commercial  
kits (Diagnosticum Ltd Budapest) by photometric method. Platelet aggregation was 
measured in whole blood and in PRP. PMA induced ROS production; endogenous 
antioxidant and prooxidant status of these patients were measured as it was described 
above. Platelet aggregation: Platelet aggregation was measured in PRP and in whole blood 
as it was described above. In the latter case area under the aggregation curves were 
calculated as well, using Origin 6.0 data analyzing and graphing software. Collagen 
induced platelet aggregation, and PMA induced ROS production were measured in the 
presence of 0, 40, 80, 160 µU/ml insulin (Actrapid), too. Statistical analyses: Student’s 
paired and unpaired t-test and one way analysis of variance were used. Differences were 
considered significant, when p was less than 0.05. The results were expressed as mean ± 
SD or in percentage. 
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3. Results 
3.1 Results of the first series of experiment 
3.1.1 Results of clinical chemistry measurements 
Red blood cell numbers were similar in the three groups, but haemoglobin concentration 
was significantly lower and leukocyte number was higher in Acute group, compared to the 
Elective and Control ones, in the course of the study 
3.1.2 Platelet aggregation in platelet-rich plasma  
ADP and Collagen were selected as aggregation inductors. These agents were used to 
control the efficacy of the two most frequently used groups of antiplatelet drugs, the 
cyclooxygenase (COX) inhibitors and adenosine diphosphate (ADP) receptor antagonists.   
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Fig. 1. ADP (5 and 10 µM) induced aggregation in platelet rich plasma. Antiplatelet therapy 
seemed to be effective in both patients groups using 5 and 10 µM ADP, as inductor in 
PRP.*= p<0.05 vs.  Control, **= p<0.01 vs. control. 
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Fig. 2. Maximum values of collagen (2 μg /ml) induced platelet aggregation in PRP, 
compared to Control. *= p<0,05, **=p<0.01 compared to controls. 
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In figure 1 and 2 the ADP- and in figure 3 the collagen induced aggregation maximums 
were summarized, and compared to the values of healthy subjects. According to our data 
antiplatelet therapy received by both patients groups were effective on the level of isolated 
thrombocytes in the whole observation time.  Platelet aggregation in Control group was 
within the normal range either ADP or collagen was used as inductors (61-91% of ADP, and 
64-92 of collagen), contrarily in both groups of patients a significantly reduced response to 
ADP and Collagen were measured, signing an effective anti-platelet therapy. 
3.1.3 Investigation of platelet aggregation in whole blood 
3.1.3.1 ADP induced platelet aggregation in acute and elective groups 
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Fig. 3. ADP induced platelet aggregation in Elective group, compared to Control (red line) 
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Fig. 4. ADP induced aggregation in Acute group, compared to Control (red line). 
ADP induced platelet aggregation in whole blood was similar in Acute and Elective and 
Control groups before the surgery. In the Elective group ADP induced platelet aggregation 
did not changed significantly in the course of the study. In the Acute group a significant 
gradual increase was observed in the function of time, with a four times increase at the end 
of the week (Figure 4). 
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3.1.3.2 Collagen induced aggregation in whole blood 
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Fig. 5. Collagen induced platelet aggregation in Elective group. 
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Fig. 6. Collagen induced aggregation in whole blood in Acute group.  
In whole blood of healthy subjects, the collagen induced platelet aggregation started  
with one minute delay. In the patient groups, collagen induced aggregation started 
without delay, mainly in Acute group, one week after the surgery. Application of  
the inductor in this case resulted in an immediate induction of platelet aggregation. The 
effect of antiplatelet therapy was detected in platelet- rich plasma was missed in whole 
blood.  
3.1.4 Investigation of antioxidants   
3.1.4.1 GSH level 
Before surgery GSH levels were similar in the three groups. In patients groups a transient 
reduction occurred 2 hours after and one day after the surgery, but returned to the baseline 
level one week after the surgery. 
3.1.4.2 Plasma thiol groups 
Before the surgery the plasma SH-group concentration of the patient groups did not differed 
from each other or the healthy controls, but a transient, significant reduction was measured 
2 hours and 24 hours after surgery in both patients groups, which returned to the normal 
level 1 week later. 
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3.1.4.3 SOD activity 
Before surgery SOD activity was lower in both patients groups, compared to Control, 
however SOD activity in Elective group was higher than in Acute group, and remained 
unchanged during the study. In Acute group SOD level decreased further 24 hours after the 
surgery. SOD levels of patients groups remained below the normal range in the course of 
the whole study (Figure 7.) 
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Fig. 7. Changes in SOD activity. *= p<0.05, **=p<0.01, **=p<0.005, +=p<0.05 vs. elective, 
#=p<0,05 vs. before surgery 
Before surgery SOD activity in both patients groups were lower compared to healthy 
volunteers. This low level decreased further significantly n Acute group until the 24th hour 
of reperfusion and remained in this low level during the study. In elective group SOD level 
was on a constant low-level during the study. I/R injury was described almost 50 years ago, 
but the correct mediation, the way of prevention or treatment is under investigation in 
nowadays, as well. The inflammatory responses can be detected following reperfusion 
varies greatly and depends on the time and severity of ischemia, as it was measured in our 
cases too. Restoration of blood flow of ischemic tissues initiates a chain reaction of 
complications which can categorize into two main groups: regional and systemic. In our 
case restoration of blood flow in lower limb, generated a systemic response, which had been 
detected in blood samples (in serum, haemolysate, plasma) obtained in a great distance from 
the intervention. 
3.1.5 Investigation of prooxidants 
3.1.5.1 PMA induced free radical production 
Before surgery PMA induced ROS production was higher in Acute than in Elective and 
Control groups. This value elevated further in the course of the study. Free radical generation 
was characterized with four parameters: 1. the lag-time: the time elapsed between the 
induction and the beginning of the free radical production, 2. maximum of free radical 
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production corrected to the WBC numbers, 3. the Slope: the rate of rise of  the ascending part 
of the free radical generation curves  and the WBC numbers (Figure 8.). 
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Fig. 8. Upper left panel: white blood cell numbers, upper right panel: lag time, bottom left 
panel: slope of free radical curve, bottom right panel: maximal free radical production. 
***=<0.001 vs. control, +++=p<0.001 vs. elective, #= p< 0.01 vs. before surgery). 
In Acute group WBC numbers were significantly higher (upper left panel) and Lag time was 
significantly shorter (upper right panel) before and one week after the surgery, than the 
similar values in Elective and Control Groups (*=p<0.05 vs. Control, # = p<0.05 vs. Elective 
groups). Slope of the free radical producing curves became steeper in acute and elective 
groups, signing that more and more active WBC are present before and one week after the 
surgery, but in Acute group this free radical generation was significantly higher, than in the 
other two groups. The maximum of free radical production continuously elevated both in 
acute and in elective groups, but these elevation in acute group was several times higher 
than it was measured in elective group (figure 8.). 
3.1.5.2 Investigation of lipid peroxidation due to measurement of MDA in plasma and in 
red blood cell haemolysate 
It is a well known fact, that one of the main consequence of long-lasting atherosclerosis is 
the significant decrease in the polyunsaturated fatty acid (PUFA) content of the membranes, 
due to saturation of the membrane lipids which responsible for the rigidity of the 
membranes. MDA is one of the lipid peroxydation end products, generated in the course of 
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free radical induced peroxydation of PUFA. MDA is frequently used as a lipid peroxydation 
marker in biological tissues. 
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Fig. 9. MDA level in red blood cell (RBC) hemolysate (left panel) and in plasma (right 
panel), *= p<0.05 vs. Control,   **= p<0.01 vs. Control, ***= p<0.0051 vs. Control +=p<0.05 vs. 
Elective, #=p<0.05 vs. before surgery 
Surprisingly, in our case MDA concentration of erythrocyte membrane remained in a 
standard, relatively low level during the whole study, in the Acute group. We speculated 
about the background of this phenomenon, and finally we concluded that the long-lasting 
hypoxia preceeded the surgery may exhausted of the PUFA contents of the lipidmembranes. 
At the same time, plasma MDA of Acute group (right panel) were significantly higher than 
in Elective and Control groups, and elevated further 24 hours after the surgery, and 
returned to the baseline one week after the surgery. In Elective group a bell-shaped 
elevation appeared which peaked 2 hours after surgery (Figure 9. right panel). 
3.1.5.3 Changes in MPO 
In spite of MPO have not been evaluated in routine clinical chemistry studies, according to a 
recent study of Brevetti and coworkers its elevated level, but not C-reactive protein, predicts 
cardiovascular risk in peripheral arterial disease (Brevetti G , 2008). According to an other 
study it is a marker of myocardial infarction too. The base-line myeloperoxidase level 
independently predicts the risk of major adverse coronary events within 30 days.  
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Fig. 10. Myeloperoxidase level in Control, Elective and Acute groups. MPO level both in 
Elective and Acute groups were significantly higher than in Control before surgery, than 
after a transient decrease in the postoperative period returned to the preoperative level. 
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(Brennan ML et al 2003). MPO is a hydrogen peroxide oxidoreductase, specifically found on 
mammalian polymorphonuclear leukocytes (PMN), responsible for the bactericidal 
capability of these cells. PMN activation and mediator release are partially responsible for 
the morbidity and mortality of revascularization of ischemic lower limb, regardless of the 
mode of intervention, surgery or application of thrombolytics. 
3.1.5.4 Conclusion of the first series of the experiments 
Ischemia/reperfusion injury, accompanied by revascularization surgeries of lower limb, 
was in the focus of the present study. This problem has great importance in the clinical 
practice because of its poor outcome (postoperative mortality is 15-60%). Tissue injury 
appears not only under ischemia, but after restoration of the blood flow in the formerly 
ischemic areas, due to the reperfusion injury, as well (Yasin) NM et al. 2002), (Arato et al 
2009). Ischemia reperfusion injury of lower limb is accompanied by muscle changes with 
progressive micro-vascular damage, and affects all circulating cells (RBC, WBC, and PLT), 
as well. These cells are in connection with each other and with cells of the vessel walls, too. 
Inflammatory response following reperfusion varies greatly, and depends on the time and 
severity of ischemia. According to our results in accordance with several other studies, the 
duration and severity of ischemia is proportional to the damage occurred after it. Studying 
thrombocyte function and antioxidant prooxidant status of our unique patient groups, 
several new aspects of ischemia reperfusion injury were revealed. Peripheral arterial disease 
is a common progressive disorder that attaches the circulation of the legs, particularly in 
people over 55 years, strengthening in these patients the greatly increased risk of heart 
attack or stroke, and of dying within a decade. Several aspects of the problem were 
intensively studied, but platelet function during the restoration of the circulation of ischemic 
lower limb was hardly investigated before. It was revealed in this study that an effective 
antiaggregating therapy was applied in these patients, and effectively reduced the 
aggregation induced by ADP and collagen in PRP, but this reduction in whole blood was 
completely disappeared, both in ADP and collagen induced aggregation in Acute and 
Elective groups too. Above this a highly significant increase in platelet aggregation was 
measured in whole blood, in response to both types of inductors, one week after the surgery 
in Acute group. We concluded on the basis of our result that the long-lasting hypoxia is 
responsible for the increased PLT aggregation in whole blood, as the consequence of the 
shift of the antioxidant-prooxidant balance to the prooxidant direction lead to the increased 
response to aggregation inductors. 
3.2 Results of the second series of experiments 
3.2.1 Clinical chemistry data 
Monitoring thrombocyte function and antioxidant prooxidant status of diabetic patients 
with peripheral arterial disease is inevitably important, because of the increased risk of 
complication. Patients suffering from both diabetes and PAD are at risk of developing 
critical limb ischemia, ulceration and potentially requiring limb amputation. In addition, 
diabetes complicates surgical treatment of PAD and impairs vascular functions. The 
presence of diabetes increases the frequency of intermittent claudication. The relative risk of 
amputation in diabetic population is 12,4-fold higher compared to the non diabetic patients 
(95%, 10,9-14,9), and this value doubles above 65 years. Diabetes increases the sensing of 
shear stress and the response to vasoconstrictor stimuli, reducing the recruitment and 
dilatation of collateral arteries (Brennan ML et al 2010).  
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Group of  
patients 
Glucose Triglyceride Cholesterol 
DM1 11.4 ±1.6 1.9 ± 0.3 4.3±0.6 
DM2 7.3 ±0.7 4.3 ±1.4 5.2 ±0.7 
Healty 4.82 ±0.27 1.1±0.15 4.2 ±0.5 
Normal values 4.2-6.1 mmol/l 0.4-1.7 mmol/l 3.7-5.2 mmol/l 
Table 4. Clinical Chemistry of Control subjects and DM1 and DM2 patients. 
Glucose and triglyceride levels of diabetic patients were higher than the normal values. The 
mean value of cholesterol level was within the normal range, but individually high values 
were measured, as well.  
3.2.2 Investigation of platelet aggregation 
3.2.2.1 Investigation of PLT function in platelet rich plasma 
Investigation of platelet function by turbidimetric method in PRP is a more frequently  
used method, than impedance measurement in whole blood. Our own investigations 
focused our attention on the usefulness of the parallel measurements. There are several 
advantages using both methods parallel, e.g. in PRP platelet function can be measured 
independently from other circulating cells. It is very advantageous if we investigate  
the effect of antiplatelet drug in a specific direction. Contrary, in whole blood the effects of 
the other components of circulating cells of blood (leukocytes, red blood cells) can be 
studied together. 
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Fig. 11. ADP induced platelet aggregation in PRP of diabetic patients with PAD.  
All parameter were measured in DM1 and DM2 Patients were reduced, compared to 
Control. In DM2 patients Slope of the aggregation curve was significantly higher compared 
to Elective groups.  
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 Collagen-induced aggregation (2 µgml) in PRP
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Fig. 12. Collagen induced platelet aggregation in PRP of diabetic patients with PAD.  
3.2.2.2 Investigation of ADP induce platelet aggregation in whole blood in control and 
diabetic patients with PAD 
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Fig. 13. ADP induced platelet aggregation of healthy and diabetic patients with PAD in the 
function of time. However patient’s data were higher in every time points compared to 
Control, significant difference can’t be detected. 
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Fig. 14. Area under the ADP induced platelet aggregation curves (AUC). AUC of patients 
with PAD were significantly higher (p<0.05), than that of Control 
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3.2.2.3 Investigation of PLT function in whole blood in control and diabetic patients  
collagen induce platelet aggregation in whole blood 
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Fig. 15. Collagen induced platelet aggregation in whole blood of healthy and diabetic subjects 
with PAD in the function of time. Platelet aggregation of diabetic patients was higher in each 
point of times, but significant difference has not been observed among the groups. 
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Fig. 16. AUC of the platelet aggregation curves of healthy and diabetic patients. Significant 
differences were measured among DM1 and DM2 groups, compared to each other (#)., and 
between DM1 and Control. 
3.2.3 Antioxidant and prooxidant levels 
Plasma GHS levels were similar in the three groups, however SOD activity was significantly 
lower in both patients groups, compared to Control (Figure 17). WBC numbers in the DM1 
group was the double and ROS production/103 WBC was 20 times higher in DM1 group 
than in Control and was double of the DM2 (Fig.18) 
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Fig. 17. SOD activity was significantly lower in patients groups than in Control. 
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Fig. 18. PMA induced ROS production was higher in patients then in Control 
3.2.4 In vitro effects on insulin on platelet aggregation in whole blood 
3.2.4.1 In vitro effect of actrapid insulin on collagen induced platelet aggregation in 
whole blood of healthy volunteers, DM1 and DM2 patients with PAD was investigated 
Actrapid insulin exerts its effect within a short time in patients too, that was the reason why 
we chose this. Platelet aggregation was expressed in Ohm, and area under the curves was 
calculated as well, and we expressed in %. AUC without insulin was considered as 100%. 
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Fig. 19. Collagen induced aggregation in healthy volunteer’s whole blood in the function of 
time, in the presence or absence of Actrapid insulin. A significant decrease occurred in the 
presence of 80 µU/ml of insulin     
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Fig. 20. AUC in healthy subjects. Significant decrease was detected in the presence of 80 
µU/ml of insulin, considering 100% of AUC without insulin 
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Fig. 21. Collagen induced platelet aggregation in the function of time on whole blood in 
DM1 patients. DM1 patient’s blood was sensitive to each concentration of insulin, without 
any significant difference among the groups. 
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Fig. 22. AUC of collagen induced platelet aggregation curves in DM1. The three insulin 
concentration caused similar, but significant decrease in the aggregation. 
 
 
Fig. 23. Collagen induced platelet aggregation in DM2 patients. Insulin was ineffective on 
collagen induced platelet aggregation. 
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3.2.5 Effect of exogenous insulin on PMA induced ROS production in whole blood 
Insulin effect on the maximum of PMA induced ROS production was investigated, as well.  
The presence of insulin in whole blood was able to reduce PMA induced ROS production in 
whole blood in healthy subjects and that of DM1 patients’ blood too, but not in DM 2 
patients (Figure 24.) 
 
 
Fig. 24. Insulin was not able to reduce area under platelet aggregation curve in blood 
samples of patients with DM2. 
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Fig. 25. Effect of insulin on PMA induced ROS production on whole blood of Control, DM1 
and CM2 patients’ whole blood, in vitro. 
3.3 Summary of data obtained from investigation of diabetic patients blood 
The presence of DM1 or DM2 diabetes differently influenced the thrombocyte function and 
antioxidant status of PAD patients, and the in vitro effects of insulin on collagen induced 
platelet aggregation and PMA induced ROS generation.  
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Investigating platelet aggregation in whole blood of patients neither in ADP, nor  
in collagen induced aggregation curves differed significantly from each other or the control.  
Calculating area under curves (AUC), significant differences were revealed, showing that 
platelets of DM1 patients was more sensitive to both inductors than that of  
in other two groups (Figure 13-16). This increased sensitivity was accompanied by lower 
SOD activity (Figure 17.) and highly significant increase in PMA induced ROS generation 
(Figure 18.). 
In vitro effects of insulin on collagen induced platelet aggregation, and PMA induced ROS 
generation were also investigated in the presence of 0, 40, 80, 160 μU/ml insulin in the 
whole blood. A U-shaped inhibition in collagen induced aggregation was detected in 
healthy subjects, a constant decrease in DM1 patients, without dose dependence, but insulin 
was ineffective in DM2 patients blood (figure 19-25). The maximum values of PMA induced 
ROS generation was significantly higher than in other two groups, but insulin pre-treatment 
was able to reduce it. Insulin was able to reduce the low ROS levels were induced by PMA 
in the blood donor’s blood, but not in DM2 patient’s blood.  
4. Conclusion  
Reconstruction of blood flow in the formerly ischemic tissues induces chain reactions, which 
affect not only the tissues are involved, but threats the integrity of the whole organism, 
causing multiorgan failure and death. The irreversible muscle cell damage begins 3 hour 
after ischemia and completed about within 6 hours (Blaisdell W. 2002). Tissue damage 
induced by the revascularization surgery of lower limbs had been in the focus of our 
studies. Our main aims were to study and characterize the role of the duration of the 
hypoxia on the thrombocyte function, and on the other circulating cells, especially on the 
leukocytes. ADP and collagen were used as platelet aggregation inductors. ADP is able to 
potentate the effects of other inductors, such as thrombin, due to stimulate and stabilize the 
thrombus. Collagen appears in the blood steam in the course of the injury of endothelial 
lineage. Collagen directly acts due to GPIIbIIIa receptors, and indirectly by Von-Willebrand 
factor, induces platelet aggregation and increases the adherence of platelet to the vessel 
wall, too.  
Our studies can be considered new, in the respects of the parallel measurement of 
aggregation in platelet rich plasma and in whole blood within the same samples, at the same 
time. We revealed significant differences using the two methods. In isolated thrombocyte 
the effectiveness of antiplatelet therapy can be tested directly on the thrombocyte itself, 
during the hospitalization. In whole blood, the modulating effects of other cellular and non 
cellular components of blood can be studied. The disturbances in antioxidant/prooxidant 
balance are in the background of this phenomenon. The most surprising results were in our 
studies, that in PRP a satisfactory aggregation inhibition was detected in both the Acute and 
Elective groups (Figure1 and 3), but in whole blood (Figure 3., 4.,5., 6.) a highly significant 
elevation in ADP and collagen induced aggregation were revealed in the Acute group, 
compared to the Elective and Control ones. We concluded that the increased leukocyte 
numbers, the elevated free radical production of the individual leukocytes, and the 
exhausted antioxidant capacity, mainly the significant reduction in SOD activity, had 
important role (Figure 7. and 8). We pointed out the importance of the increase of 
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prooxidants, while antioxidant capacity decreases especially in Acute group and in a less 
extensive way in Elective group too. 
It has to be mentioned that SOD deficiency is a highly important determinant of the 
increased ROS production and the increase in platelet aggregation one week after the 
surgery. Pipinos and co-workers published that, the SOD enzyme mutation of 
gastrocnemius muscle of rats is a risk factor of PAD, (Pipinos II and Swanson SA 2008). 
Intracellular GSH and the plasma –SH groups possess remarkable antioxidant capacities. 
Before the surgery their levels were almost equal in the three groups, but after surgery a 
small but significant transient reduction was measured in their levels, mainly in the Acute 
group. Conflicting results are published about the effects of volatile anaesthetics on 
oxidative stress, and some local anaesthetics can cause transient decrease in GSH level in 
skeletal muscles (Jia-Li Luo, et al 1996). It can be supposed that transient decrease in GSH 
level is partially caused by the surgical intervention. Further alterations are caused by the 
disease itself, due to the sclerotic vessels, and/or the presence of hypertension, and other 
disturbances. These states also complicated by increased free radical generation, which 
usually increased further by the surgical intervention. Activated platelets play definitive 
role in the development of atherosclerosis and increase of the risk of surgical 
interventions. In spite of these there are only few data which can highlight the 
background of the poor prognosis of PAD and the role of thrombocytes in these processes. 
Other risk-factors which have definitive role, the activated complement system (Beinrohr 
L), leukocyte-thrombocyte interaction, and the increased endothelin release. The 
consequences of IR affect not only the great conduit vessels, but microcirculation is also 
affected (Kaszaki et al 2006). In the course of the animal studies they improved the 
protective effects of endothelin-A receptor antagonists and preconditioning against IR 
induced micro-vascular alterations. 
Diabetes is also a well defined risk factor which worsens the outcome the surgical 
intervention. In the second series of our study thrombocyte function and antioxidant 
prooxidant status of diabetic patients with peripheral arterial disease were investigated 
and effects of exogenous insulin were tested. Platelet aggregation of PRP in diabetic 
patients was reduced compared to healthy blood donors signing the efficacy of their 
antiplatelet treatment. This difference failed to appear in whole blood. Free radical 
productions were significantly higher and SOD enzyme activities were significantly lower 
in diabetic patients compared to control. Low concentrations of insulin reduced the 
aggregation and free radical production in healthy and Type 1 diabetic patient’s blood but 
failed to induce such effects in Type 2 diabetic ones. Insulin resistance is developed 
against not only the metabolic effects of insulin, but against other activities of this 
important hormone, as well. Revealing the alterations caused by surgical intervention in the 
function of circulating cells is inevitably important to improve the outcome of these 
procedures and reduce the complication of surgical intervention and facilitate recovery. 
Insulin is a vital hormone which essential for the glucose uptake of skeletal muscle and 
the heart. Insulin resistance increases the harmful effect of IR. Insulin effect can be 
improved and free radical production can be decreased by antioxidant, signing the 
important roles of free radicals in the pathogenesis of IR. Mice overexpressing 
extracellular SOD are less sensitive to IR (Sheng H et al 1999), signing that endogenous 
antioxidants have important role in tissue protection.  
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Present study support the importance of antioxidant prooxidant  equilibrium and the role of 
endogenous antioxidants. 
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